Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +20.0% | +39.4% | 2 / 3 | +12.3% | -2.13 pp | +0.23 pp | +5.7% | 0.50 | 8.65 | 822 | +12,3% | 36,1 | +18,7% | 8.65 | 12.57 | −31,2% |
| Pts | 4 | 8 | 8 | 4 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.470 (close price on 2026-10-19)EPS (TTM): 748,3
Financial charts
1.Revenue & growth
VND bn822Q2/26
1.Revenue & growth
VND bn822Q2/26
2.Profit & growth
VND bn35,7Q2/26
3.Profit mix (Penman)
VND bn174Q2/26
4.Margins & cost structure
%9.3%Q2/26
5.Returns & cash cycle
% · days5.0%Q2/26
6.Earnings quality & cash
VND bn1.185Q2/26
7.Asset structure
VND bn7.660Q2/26
8.Funding & debt health
VND bn · times7.660Q2/26
9.Revenue backlog
VND bn2.399Q2/26
10.Valuation
times · %8,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %171Q2/26
Adjusted EPS growth, latest quarter
17.3%
Average adjusted EPS growth, 3 quarters
38.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.1%
Source: vnstockData through Q2/26